ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Morbidity"

  • 2018 American Transplant Congress

    Evaluating Center Performance beyond Patient and Graft Survival

    S. Asrani, G. Saracino, R. Bahirwani, G. McKenna, G. Klintmalm, J. Trotter.

    Baylor University Medical Center, Dallas, TX.

    Introduction: LT centers are judged by patient survival at 1-yr post LT; however risk incurred on the waitlist or center specific practices post LT are…
  • 2018 American Transplant Congress

    Treatment of HCV Infection in Renal Transplant Recipients

    M. Rial, L. Tana, C. Alonso, H. Curcio, E. Chulluyan, D. Casadei.

    Renal Transplant Unit, Instituto de Nefrologia Nephrology, Buenos Aires, Argentina.

    HCV infection is associated to chronic hepatitis, cirrhosis, hepatic carcinoma and increased incidence of diabetes. Combination of new antiviral drugs have demonstrated utility in liver…
  • 2018 American Transplant Congress

    Morphometric and Metabolic Correlates of Frailty in Pancreas Transplant Recipients

    R. Parsons, J. Wolosyn, R. Lynch.

    Surgery, Emory University, Atlanta, GA.

    Background: Prediction of survival and health resource utilization in the pancreas transplant population requires novel approaches to risk stratification. We studied whether sarcopenia and osteopenia,…
  • 2018 American Transplant Congress

    The Grade of Pre-Transplant Portal Vein Thrombosis in Liver Transplant Recipients Impacts Graft and Patient Survival

    M. Safwan, M. Sobolic, S. Nagai, R. Schilke, K. Collins, A. Yoshida, M. Abouljoud, M. Rizzari.

    Henry Ford Transplant Institute, Henry Ford Health System, Detroit, MI.

    Background: Portal vein thrombosis (PVT) in the pre-transplant (pretx) setting makes liver transplantation technically challenging and is also known to affect post transplant outcomes. Few…
  • 2018 American Transplant Congress

    Proteinuria is Associated with Increased Risk for Cardiovascular Disease after Kidney Transplantation

    R. Rahamimov,1,2,3 M. Molcho,3 I. Vahav,3 A. Chagnac,1,3 E. Mor,2,3 B. Rozen-Zvi.1,3

    1Nephrology and Hypertension, Rabin Medical Center, Petach Tikva, Israel; 2Transplantation, Rabin Medical Center, Petach Tikva, Israel; 3Sackler Faculty of Medicine, Tel- Aviv University, Tel- Aviv, Israel.

    Introduction: Proteinuria is a risk factor for cardiovascular (CV) disease in the general population and occurs commonly after kidney transplantation. The association between proteinuria and…
  • 2018 American Transplant Congress

    Hyperkalemia in the Early Post Renal Transplant Period

    E. Christie, J. Okel, M. Gowrishankar.

    Division of Nephrology, University of Alberta, Edmonton, AB, Canada; Division of Nephrology, University of Alberta, Edmonton, AB, Canada; Division of Pediatrics, University of Alberta, Edmonton, AB, Canada.

    Hyperkalemia is a recognized and potentially life threatening complication post renal transplantation. Aside from delayed graft function, the most frequent culprit identified is pharmacotherapy. Many…
  • 2018 American Transplant Congress

    Platelet Counts as Predictors of Short- and Long-Term Outcomes in Liver Transplantation: Cassandras or Just Rats on a Sinking Ship?

    I. Amygdalos,1 Z. Czigany,1 J. Böcker,1 F. Meister,1 M. Krebbers,1 D. Morales Santana,1 J. Bednarsch,1 W. Schöning,1 F. Ulmer,1 G. Koek,3 D. Kroy,2 F. Tacke,2 C. Trautwein,2 U. Neumann,1 G. Lurje.1

    1Department of General, Visceral and Transplantation Surgery, University Hospital RWTH Aachen, Aachen, Germany; 2Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany; 3Department of Internal Medicine, Maastricht University Medical Center, Maastricht, Netherlands.

    BackgroundThrombocytopenia is associated with higher morbidity and mortality following partial hepatectomy and orthotopic liver transplantation (OLT). Here we investigated platelet counts (PC) as a predictor…
  • 2017 American Transplant Congress

    A Comparison of Desensitization Protocols: Rituximab with/without Plasmapheresis in ABO-Incompatible Living Donor Liver Transplantation.

    E. Lee, S. Kim, S. Lee, S.-J. Park.

    Center for Liver Cancer, National Cancer Center, Goyang, Korea

    Background: Plasmapheresis is a desensitization method used prior to ABO-incompatible (ABO-I) living donor liver transplantation (LDLT). However, studies on its usefulness in the rituximab era…
  • 2017 American Transplant Congress

    Course and Outcome of Renal Transplant Recipients Admitted to the Intensive Care Unit (ICU): Long Term Follow-Up.

    A. El-Agroudy,1 A. Alqahtani,1 B. Dandi,2 E. Farid,2 A. Alaradhi.2

    1Medicine, Arabian Gulf University, Manama, Bahrain; 2Nephrology, Salmaniya Medical Complex, Manama, Bahrain

    Background. The goal of this study was to evaluate the course and outcome of renal transplant recipients admitted to ICU and to analyze factors determining…
  • 2017 American Transplant Congress

    Predictive Value of Post Reperfusion TEG in Peri-Operative Outcomes During Liver Transplant.

    P. Sheiner, A. Sulejamnovic, J. Salm, E. Silver, C. Rochon.

    Transplant Surgery, Hartford Hospital, Hartford, CT

    Liver transplantation (LT) is the main treatment for patients with end-stage liver disease. During a liver transplant, persistent coagulations defects and fibrinolysis can be an…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 12
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences